LUFRANO, DANIELA; TREJO, SEBASTIÁN A.; LLOVERA, RAMIRO E.; SALGUEIRO, MARIANO; FERNANDEZ, GIMENA; MARTÍNEZ DAMONTE, VALENTINA; GONZÁLEZ FLECHA, F. LUIS; RAINGO, JESICA; ERMÁCORA, MARIO R.; PERELLÓ, MARIO

Ghrelin binding to serum albumin and its biological impact

MOLECULAR AND CELLULAR ENDOCRINOLOGY.; Año: 2016 vol. 436 p. 130 - 140

LAURA SOSA; RAMIRO LLOVERA; MICHELE SOLIMENA; MARIO R. ERMÁCORA

Biochemical, biophysical, and functional properties of ICA512/IA-2 RESP18 homology domain.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS; Lugar: Amsterdam; Año: 2016 vol. 1864 p. 511 - 522

LLOVERA RE, DE TULLIO M, ALONSO LG, LEISSRING MA, KAUFMAN SB, ROHER AE, DE PRAT GAY G, MORELLI L, CASTAÑO EM.

The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis.

JOURNAL OF BIOLOGICAL CHEMISTRY; Año: 2008 p. 17039 - 17048

MORELLI L, LLOVERA RE, ALONSO LG, FRANGIONE B, DE PRAT-GAY G, GHISO J, CASTAÑO EM.

Insulin-degrading enzyme degrades amyloid peptides associated with British and Danish familial dementia.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS; Año: 2005 p. 808 - 816

MORELLI L, LLOVERA RE, MATHOV I, LUE LF, FRANGIONE B, GHISO J, CASTAÑO EM.

Insulin-degrading enzyme in brain microvessels: proteolysis of amyloid {beta} vasculotropic variants and reduced activity in cerebral amyloid angiopathy.

JOURNAL OF BIOLOGICAL CHEMISTRY; Año: 2004 p. 56004 - 56013

MORELLI L, LLOVERA R, GONZALEZ SA, AFFRANCHINO JL, PRELLI F, FRANGIONE B, GHISO J, CASTANO EM.

Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme.

JOURNAL OF BIOLOGICAL CHEMISTRY; Año: 2003 p. 23221 - 23226

MORELLI L, LLOVERA R, IBENDAHL S, CASTAÑO EM.

The degradation of amyloid beta as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses.

NEUROCHEMICAL RESEARCH; Año: 2002 p. 1387 - 1399